ask="N/A"
ask_size="N/A"
average_daily_volume="610671"
bid="N/A"
bid_size="N/A"
book_value="11.38"
change="+0.92"
change_from_200_day_moving_average="10.02"
change_from_50_day_moving_average="1.03"
change_from_52_week_high="-18.03"
change_From_52_week_low="29.85"
change_in_percent="+1.22%"
close="76.37"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.66"
eps_estimate_next_year="-6.66"
ex_dividend_date="N/A"
float_shares="37661000"
high="77.05"
high_52_weeks="94.40"
last_trade_date="1/5/2017"
last_trade_price="76.37"
last_trade_size="31145"
last_trade_time="4:00pm"
low="73.61"
low_52_weeks="46.52"
market_capitalization="3.12B"
moving_average_200_day="66.35"
moving_average_50_day="75.34"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.67"
open="75.60"
pe_ratio="N/A"
peg_ratio="-0.38"
percent_change_from_200_day_moving_average="+15.10%"
percent_change_from_50_day_moving_average="+1.36%"
percent_change_from_52_week_high="-19.10%"
percent_change_from_52_week_low="+64.17%"
previous_close="75.45"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.63"
price_per_sales="24084.46"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="9.31"
stock_exchange="NMS"
symbol="RARE"
volume="390271"
weeks_range_52="46.52 - 94.40"
